drugset
drugset / Trial / NCT02634463

Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone

NCT02634463 ↗

Phase 1 Completed 81 enrolled Janssen Research & Development, LLC
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to collect whole blood and plasma venous and capillary samples from participants taking aripiprazole, olanzapine, paliperidone, or risperidone for the development of antipsychotic immunoassays.

Timeline

Start
2015-11-09
Primary completion
2016-11-09
Completion
2016-11-09

Drugs

EvaluationDrugModalityDoseRoute
Background Aripiprazole Other / unclassified — Oral
Background Olanzapine Small molecule — Oral
Background Paliperidone Unknown — Oral
Background Risperidone Other / unclassified — Oral

Indications

No indication recorded.